바이오 촉매 및 효소 화학제품 시장 : 예측(-2034년) - 유형별, 원료별, 용도별, 지역별 분석

According to Stratistics MRC, the Global Bio-Catalyst & Enzyme Chemical Market is accounted for $786.61 million in 2026 and is expected to reach $1292.09 million by 2034 growing at a CAGR of 6.4% during the forecast period. Enzyme chemicals and bio-catalysts play a crucial role in speeding up biochemical processes while serving as environmentally friendly substitutes for conventional chemical catalysts. They are extensively applied in sectors like pharmaceuticals, food production, textiles, and biofuel manufacturing, improving efficiency, increasing yields, and lowering energy requirements. Their precise action enables selective reactions, reducing unwanted by-products and ecological harm. As industries focus on sustainable and green solutions, the importance of bio-catalysts and enzyme chemicals continues to rise. Ongoing research and technological developments are broadening their industrial applications, making them indispensable for efficient, eco-conscious, and advanced chemical and biotechnological operations.

According to the Observatory of Economic Complexity (OEC), data shows that global trade in enzymes (HS Code 3507) reached $7.63 billion in 2024, reflecting a 4.9% increase from 2023. Denmark was the top exporter at $1.79 billion, while the United States was the largest importer at $994 million. Over the past five years, enzyme trade has grown at an annualized rate of 6.51%, highlighting steady demand across industries.

Market Dynamics:

Driver:

Growing demand for sustainable and green processes

Heightened awareness of environmental protection and sustainable practices is fueling the growth of bio-catalysts and enzyme chemicals. Conventional chemical processes often produce pollutants and consume significant energy, prompting industries to adopt cleaner alternatives. Enzymes enable precise and efficient reactions while minimizing waste, supporting sustainability targets and regulatory compliance. Additionally, growing consumer demand for eco-friendly products drives industrial adoption. Companies striving to lower carbon emissions and meet stricter environmental standards increasingly rely on bio-catalysts and enzymes. Consequently, these chemicals are becoming crucial for achieving cleaner, safer, and more sustainable industrial manufacturing processes worldwide.

Restraint:

High production costs

High production expenses are a key limitation for the bio-catalyst and enzyme chemical market. Enzyme manufacturing demands sophisticated technology, strict conditions, and specialized workforce, driving up operational costs. Producing large quantities of high-purity enzymes requires significant investment in bioreactors, equipment, and quality control. These elevated costs often make enzyme-based products more expensive than traditional chemical catalysts, reducing adoption in cost-sensitive industries. Despite increasing demand, the high financial burden limits large-scale implementation. Industries must carefully manage cost versus sustainability priorities, making price a significant challenge that constrains market growth and delays broader integration of bio-catalysts and enzyme chemicals.

Opportunity:

Increasing adoption in food & beverage innovations

Rising consumer demand for clean-label, natural, and nutritious food products creates growth potential for bio-catalysts and enzymes. Enzymes improve processing efficiency, enhance taste, texture, and shelf life, and lower energy usage. The surge in functional foods, nutraceuticals, and plant-based alternatives widens enzyme application possibilities. Additionally, enzyme solutions support environmentally friendly production practices and compliance with regulatory standards. As global consumers increasingly prioritize food quality and health, manufacturers are adopting enzyme-based technologies. This provides considerable opportunities for bio-catalyst and enzyme producers to strengthen their market position and cater to the evolving needs of the innovative food and beverage industry.

Threat:

Intense market competition

The enzyme and bio-catalyst market is challenged by strong competition from both global leaders and regional players. Large multinationals benefit from advanced technologies, loyal clients, and extensive distribution, creating hurdles for smaller companies. Meanwhile, innovative startups introducing new enzyme solutions heighten rivalry, resulting in pricing pressures and reduced profits. Companies must constantly invest in R&D, marketing, and technological improvements to sustain competitiveness. This highly competitive environment can trigger consolidation, aggressive pricing, and margin erosion, threatening profitability and long-term viability. Consequently, intense market competition remains a significant threat to the stability and growth of enzyme and bio-catalyst businesses.

Covid-19 Impact:

The COVID-19 outbreak had a notable effect on the enzyme and bio-catalyst market, disrupting global supply chains, manufacturing, and logistics. Lockdowns and movement restrictions delayed raw material procurement and slowed production, limiting growth in industrial and food sectors. Conversely, demand surged in pharmaceuticals and healthcare, as enzymes were critical in diagnostics, vaccine production, and therapeutics, partially counterbalancing declines elsewhere. The pandemic also spurred investments in biotechnology research and enzyme development for medical applications. Overall, COVID-19 both challenged and created opportunities for the market, reshaping industry priorities and emphasizing the vital role of bio-catalysts and enzymes in healthcare and innovation.

The hydrolases segment is expected to be the largest during the forecast period

The hydrolases segment is expected to account for the largest market share during the forecast period due to their broad industrial utility and capacity to catalyze hydrolysis reactions efficiently. They find applications across pharmaceuticals, food processing, biofuels, and textiles, improving production speed, output, and quality. Their capability to degrade complex biomolecules like fats, proteins, and carbohydrates makes them essential in numerous processes. The enzymes' specificity, environmentally friendly properties, and effectiveness under mild operating conditions enhance their adoption. Ongoing advancements and research continue to broaden hydrolase applications, reinforcing their dominance and establishing them as the most significant segment within the global bio-catalyst and enzyme chemical market.

The micro-organism derived segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the micro-organism derived segment is predicted to witness the highest growth rate, driven by its cost efficiency, scalability, and adaptability. Large-scale microbial fermentation enables the production of enzymes with consistent quality and abundant supply. Their broad applications span pharmaceuticals, biofuels, food processing, and chemicals, fulfilling industrial demand for sustainable and high-performance catalysts. Advances in biotechnology and genetic engineering enhance enzyme stability, activity, and specificity, further expanding applications. The increasing emphasis on green and renewable industrial processes accelerates the adoption of micro-organism derived enzymes, establishing this segment as the leading growth driver in the global bio-catalyst and enzyme chemical market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by a strong industrial base and advanced biotechnology capabilities. Leading manufacturers and widespread applications in pharmaceuticals, biofuels, food processing, and chemical sectors contribute to its dominance. Government support, R&D investments, and regulations favoring sustainable industrial practices further promote enzyme adoption. The region benefits from continuous innovation, growing healthcare requirements, and emphasis on environmentally friendly production methods. With a blend of technological advancement, industrial diversification, and high consumer awareness, North America remains the most significant regional player, accounting for the largest portion of the global bio-catalyst and enzyme chemical market.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to rapid industrial growth, expanding food and pharmaceutical sectors, and increasing biotechnology investments. Rising consumer awareness of sustainable and eco-friendly products, higher disposable incomes, and supportive government policies for green production fuel adoption. Countries like China, India, and Japan show strong demand for enzyme solutions in biofuels, food processing, and pharmaceuticals. Technological progress, enhanced research initiatives, and favourable regulations further drive market expansion. Consequently, Asia-Pacific is emerging as the region with the fastest growth, offering significant opportunities for bio-catalyst and enzyme chemical companies.

Key players in the market

Some of the key players in Bio-Catalyst & Enzyme Chemical Market include AB Enzymes, BASF SE, Codexis Inc., DuPont de Nemours Inc., Dyadic International Inc., DSM (dsm-firmenich), Lonza Group Ltd., Novozymes A/S (Novonesis), Sapporo Enzyme Co. Ltd., Soufflet Group, Amano Enzyme Inc., Chr. Hansen, Biocatalysts Limited, Prozomix Limited, Advanced Enzyme Technologies, Agrivida Inc., Iogen Corporation and MetGen Oy.

Key Developments:

In August 2025, DuPont de Nemours, Inc., The Chemours Company and Corteva, Inc. announced a settlement to comprehensively resolve all pending environmental and other claims by the State of New Jersey against the Companies in various litigation matters and other state directives. The Settlement will resolve all legacy contamination claims related to the companies' current and former operating sites and claims of statewide PFAS contamination unrelated to those sites, including from the use of aqueous film forming foam.

In July 2025, BASF and Equinor have signed a long-term strategic agreement for the annual delivery of up to 23 terawatt hours of natural gas over a ten-year period. The contract secures a substantial share of BASF's natural gas needs in Europe. This agreement further strengthens our partnership with BASF. Natural gas not only provides energy security to Europe but also critical feedstock to European industries.

In July 2024, AB Enzymes is delighted to announce the signing of a rental contract for our future global headquarters at KALA | Central Campus Darmstadt. This strategic relocation marks a significant milestone in our growth journey, providing a modern and scalable environment to support our ambitious expansion plans. The new headquarters will span over 7,300 m2 of customised laboratory and office space, constituting more than 70% of the main building at the new location, with a long-term green lease agreement extending for the next 20 years.

Types Covered:

• Hydrolases
• Oxidoreductases
• Transferases
• Lyases
• Isomerases
• Ligases

Sources Covered:

• Plant-based
• Animal-based
• Micro-organism Derived

Applications Covered:

• Food & Beverages
• Cleaning Agents & Detergents
• Agriculture & Animal Feed
• Biofuel Production
• Pharma & Biotech Applications
• Water Treatment
• Specialty Chemicals

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 3032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Bio-Catalyst & Enzyme Chemical Market, By Type

• 5.1 Hydrolases
• 5.2 Oxidoreductases
• 5.3 Transferases
• 5.4 Lyases
• 5.5 Isomerases
• 5.6 Ligases

6 Global Bio-Catalyst & Enzyme Chemical Market, By Source

• 6.1 Plant-based
• 6.2 Animal-based
• 6.3 Micro-organism Derived

7 Global Bio-Catalyst & Enzyme Chemical Market, By Application

• 7.1 Food & Beverages
• 7.2 Cleaning Agents & Detergents
• 7.3 Agriculture & Animal Feed
• 7.4 Biofuel Production
• 7.5 Pharma & Biotech Applications
• 7.6 Water Treatment
• 7.7 Specialty Chemicals

8 Global Bio-Catalyst & Enzyme Chemical Market, By Geography

• 8.1 North America
  • 8.1.1 United States
  • 8.1.2 Canada
  • 8.1.3 Mexico
• 8.2 Europe
  • 8.2.1 United Kingdom
  • 8.2.2 Germany
  • 8.2.3 France
  • 8.2.4 Italy
  • 8.2.5 Spain
  • 8.2.6 Netherlands
  • 8.2.7 Belgium
  • 8.2.8 Sweden
  • 8.2.9 Switzerland
  • 8.2.10 Poland
  • 8.2.11 Rest of Europe
• 8.3 Asia Pacific
  • 8.3.1 China
  • 8.3.2 Japan
  • 8.3.3 India
  • 8.3.4 South Korea
  • 8.3.5 Australia
  • 8.3.6 Indonesia
  • 8.3.7 Thailand
  • 8.3.8 Malaysia
  • 8.3.9 Singapore
  • 8.3.10 Vietnam
  • 8.3.11 Rest of Asia Pacific
• 8.4 South America
  • 8.4.1 Brazil
  • 8.4.2 Argentina
  • 8.4.3 Colombia
  • 8.4.4 Chile
  • 8.4.5 Peru
  • 8.4.6 Rest of South America
• 8.5 Rest of the World (RoW)
  • 8.5.1 Middle East
    • 8.5.1.1 Saudi Arabia
    • 8.5.1.2 United Arab Emirates
    • 8.5.1.3 Qatar
    • 8.5.1.4 Israel
    • 8.5.1.5 Rest of Middle East
  • 8.5.2 Africa
    • 8.5.2.1 South Africa
    • 8.5.2.2 Egypt
    • 8.5.2.3 Morocco
    • 8.5.2.4 Rest of Africa

9 Strategic Market Intelligence

• 9.1 Industry Value Network and Supply Chain Assessment
• 9.2 White-Space and Opportunity Mapping
• 9.3 Product Evolution and Market Life Cycle Analysis
• 9.4 Channel, Distributor, and Go-to-Market Assessment

10 Industry Developments and Strategic Initiatives

• 10.1 Mergers and Acquisitions
• 10.2 Partnerships, Alliances, and Joint Ventures
• 10.3 New Product Launches and Certifications
• 10.4 Capacity Expansion and Investments
• 10.5 Other Strategic Initiatives

11 Company Profiles

• 11.1 AB Enzymes
• 11.2 BASF SE
• 11.3 Codexis Inc.
• 11.4 DuPont de Nemours Inc.
• 11.5 Dyadic International Inc.
• 11.6 DSM (dsm-firmenich)
• 11.7 Lonza Group Ltd.
• 11.8 Novozymes A/S (Novonesis)
• 11.9 Sapporo Enzyme Co. Ltd.
• 11.10 Soufflet Group
• 11.11 Amano Enzyme Inc.
• 11.12 Chr. Hansen
• 11.13 Biocatalysts Limited
• 11.14 Prozomix Limited
• 11.15 Advanced Enzyme Technologies
• 11.16 Agrivida Inc.
• 11.17 Iogen Corporation
• 11.18 MetGen Oy